Business Description
Adaptive Biotechnologies Corp
NAICS : 325412
SIC : 2836
ISIN : US00650F1093
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.65 | |||||
Equity-to-Asset | 0.4 | |||||
Debt-to-Equity | 0.41 | |||||
Debt-to-EBITDA | -0.56 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -1.79 | |||||
Beneish M-Score | -2.71 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.3 | |||||
3-Year EBITDA Growth Rate | -6 | |||||
3-Year EPS without NRI Growth Rate | -7.6 | |||||
3-Year FCF Growth Rate | 3.4 | |||||
3-Year Book Growth Rate | -26.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 20.69 | |||||
Future 3-5Y Total Revenue Growth Rate | 16.21 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.04 | |||||
9-Day RSI | 48.52 | |||||
14-Day RSI | 52.19 | |||||
6-1 Month Momentum % | 45.05 | |||||
12-1 Month Momentum % | -8.97 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.52 | |||||
Quick Ratio | 3.38 | |||||
Cash Ratio | 2.78 | |||||
Days Inventory | 71.76 | |||||
Days Sales Outstanding | 77.26 | |||||
Days Payable | 41.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.8 | |||||
Shareholder Yield % | 0.99 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.46 | |||||
Operating Margin % | -94.28 | |||||
Net Margin % | -110.13 | |||||
FCF Margin % | -64.59 | |||||
ROE % | -69.21 | |||||
ROA % | -31.06 | |||||
ROIC % | -51.52 | |||||
ROC (Joel Greenblatt) % | -155.58 | |||||
ROCE % | -33.99 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.28 | |||||
PB Ratio | 4.22 | |||||
Price-to-Tangible-Book | 9.33 | |||||
EV-to-EBIT | -4.25 | |||||
EV-to-Forward-EBIT | -1.95 | |||||
EV-to-EBITDA | -4.78 | |||||
EV-to-Forward-EBITDA | -2.19 | |||||
EV-to-Revenue | 4.41 | |||||
EV-to-Forward-Revenue | 1.5 | |||||
EV-to-FCF | -6.82 | |||||
Earnings Yield (Greenblatt) % | -23.53 | |||||
FCF Yield % | -12.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Adaptive Biotechnologies Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 162.469 | ||
EPS (TTM) (€) | -1.23 | ||
Beta | 1.82 | ||
Volatility % | 57.21 | ||
14-Day RSI | 52.19 | ||
14-Day ATR (€) | 0.240232 | ||
20-Day SMA (€) | 5.72205 | ||
12-1 Month Momentum % | -8.97 | ||
52-Week Range (€) | 2.148 - 6.346 | ||
Shares Outstanding (Mil) | 147.58 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Adaptive Biotechnologies Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Adaptive Biotechnologies Corp Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Adaptive Biotechnologies Corp Frequently Asked Questions
What is Adaptive Biotechnologies Corp(FRA:1HM)'s stock price today?
When is next earnings date of Adaptive Biotechnologies Corp(FRA:1HM)?
Does Adaptive Biotechnologies Corp(FRA:1HM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |